Acute Anterior Myocardial Infarction Following Single Dose Synthetic Cannabinoid (Bonsai) Use: Case Report A AB BS S T TR RA AC CT T Nowadays synthetic cannabinoid (bonsai) is the most common substance of drug abuse in young adults because of its euphoric and addictive effects. Recently, bonsai use associated acute coronary syndromes and deaths have seen among Turkish youth. Yet there is limited evidence about bonsai induced acute myocardial infarction and the exact contribution of bonsai smoking to acute coronary syndrome and its mechanism are not known. We hereby reported a case of acute anterior myocardial infarction following bonsai smoking in a young male. . The patient was diagnosed with acute anteroseptal MI and admitted to the intensive care unit. Echocardiography showed hypokinetic apical anterior septum and apex with ejection fraction (EF) of 50%. The patient received 300 mg aspirin, 600 mg clopidogrel and 100 mg/kg unfractionated heparin. Considering the probability of coronary vasospasm, intravenous nitroglycerin and adenosine was administered, however pain and ST elevation did not resolve. Due to the patient's age, thrombus-related MI was considered in diagnosis and he received 50 mg (10,000 U) tenecteplase (Metalyse®) by I.V. bolus. After 30 minutes, chest pain was alleviated and ST elevations resolved (Figure 2) . Coronary angiography showed normal coronary vessels (Figure 3 and 4) .
DISCUSSION
Due to euphoric effects, the prevalence of SC abuse has been increasing among young adults, resulting in an increase in related intoxication cases. 3 The exact mechanism of MI after SC use has not been clarified by previous reports. [4] [5] [6] [7] Patients who expe-rience MI after SC use are typically young adult smokers with no other CAD risk factors.
SCs can cause sweating, vomiting, hypertension/hypotension, chest pain, tachycardia/ bradycardia, respiratory depression, confusion, psychomotor agitation, somnolence, and sedation. 1, 2, 8 One study reported 3 adolescents who experienced ST-elevation MI after SC abuse. 4 These patients developed chest pain days after use, demonstrated ST elevation in ECG and elevated troponin in blood chemistry, although coronary angiography failed to reveal the presence of vascular disturbances. Similarly, the present case exhibited normal coronary vessels on angiography.
Data regarding pharmacologic characteristics of SC are limited. Tetrahydrocannabinol (THC) is a component of SCs hat may cause vascular thrombotic complications, coronary thrombosis, and spasms. 5, 6, 8 THC may contribute to autonomic derangements and lead to an increase in heart rate and blood pressure, increasing cardiac output and myocardial oxygen demand. 9 THC is also associated with vascular inflammation and platelet activation, plaque rupture, and increased MI risk. 4, 10, 11 SCs contribute to MI through effects on cardiovascular system. In the present case, the patient did not respond to nitroglycerin and adenosine administered to reverse possible coronary spasm. The ECG findings after thrombolytic and the absence of coronary lesions support the diagnosis of thrombus-related MI caused by SC abuse. If we performed coronary angiography on admission, total occlusion of LAD could be detected. In this situation stent would be necessary to insert for revascularization. After inserting the stent, the young patient could come across with stent restenosis. Therefore, thrombolytic therapy option for patients with this condition could consider a higher priority.
SCs bind to cannabinoid receptors with high avidity.
2,4 It was not possible to determine the dose of Bonsai used or the identity of the other vasoactive/thrombogenic substances contained in the product. However, the occurrence of MI after firsttime use indicates that SCs may be associated with a greater risk of ACS relative to other commonly abused substances.
In conclusion, unexplained deaths among SC abusers may be attributable to MI. To prevent myocardial damage and decrease associated mortality, all young patients who present to ED with chest pain should be questioned regarding SC abuse, and evaluated with ECG and cardiac enzyme biochemistry. 
